ADDIPHOS

This brand name is authorized in Ireland, Poland, United Kingdom

Active ingredients

The drug ADDIPHOS contains a combination of these active pharmaceutical ingredients (APIs):

1 Disodium phosphate dihydrate UNII 94255I6E2T - SODIUM PHOSPHATE, DIBASIC, DIHYDRATE

Read about Sodium phosphate

2 Potassium dihydrogen phosphate UNII 4J9FJ0HL51 - MONOBASIC POTASSIUM PHOSPHATE

Potassium is the principle cation in intracellular fluid. It is involved with carbohydrate metabolism, glycogen storage and protein synthesis. It is involved with transmembrane potential and profound effects on muscle. Phosphorus has many important biochemical functions in the body and is involved in many significant metabolic and enzyme reactions in almost all organs and tissues. Read about Potassium phosphate

3 Caustic potash UNII WZH3C48M4T - POTASSIUM HYDROXIDE

Read about Caustic potash

Medicine classification

This drug has been classified in the anatomical therapeutic chemical (ATC) classification system as follows:

ATC code	Group title	Classification
B05XA30	Combinations of electrolytes	B Blood and blood forming organs → B05 Blood substitutes and perfusion solutions → B05X I.V. solution additives → B05XA Electrolyte solutions
Discover more medicines within B05XA30

Authorization and marketing

This drug has been assigned below unique identifiers within the countries it is being marketed:

Country	Identification scheme	Identifier(s)
Country: GB	Medicines & Healthcare Products Regulatory Agency	Identifier(s): 137348, 52331
Country: PL	Rejestru Produktów Leczniczych	Identifier(s): 100002817, 100342476, 100426977, 100455870, 100463081